178 related articles for article (PubMed ID: 35057527)
1. Association between Levocarnitine Treatment and the Change in Knee Extensor Strength in Patients Undergoing Hemodialysis: A Post-Hoc Analysis of the Osaka Dialysis Complication Study (ODCS).
Matsufuji S; Shoji T; Lee S; Yamaguchi M; Nishimura M; Tsujimoto Y; Nakatani S; Morioka T; Mori K; Emoto M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057527
[TBL] [Abstract][Full Text] [Related]
2. Effects of Levocarnitine on Cardiac Function and Renal Anemia in Hemodialysis Patients.
Higuchi T
Contrib Nephrol; 2018; 196():96-100. PubMed ID: 30041211
[TBL] [Abstract][Full Text] [Related]
3. Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis.
Kuwasawa-Iwasaki M; Io H; Muto M; Ichikawa S; Wakabayashi K; Kanda R; Nakata J; Nohara N; Tomino Y; Suzuki Y
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33139659
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis.
Hanai T; Shiraki M; Imai K; Suetugu A; Takai K; Shimizu M
Nutrients; 2020 Jun; 12(7):. PubMed ID: 32610446
[TBL] [Abstract][Full Text] [Related]
5. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of monitoring free carnitine levels for L-carnitine supplementation in hemodialysis patients to maintain carnitine sufficiency and nutritional factors.
Kumagai E; Hosohata K; Furumachi K; Takai S
Ther Apher Dial; 2021 Oct; 25(5):595-606. PubMed ID: 33470531
[TBL] [Abstract][Full Text] [Related]
7. Levocarnitine Decreases Intradialytic Hypotension Episodes: A Randomized Controlled Trial.
Ibarra-Sifuentes HR; Del Cueto-Aguilera Á; Gallegos-Arguijo DA; Castillo-Torres SA; Vera-Pineda R; Martínez-Granados RJ; Atilano-Díaz A; Cuellar-Monterrubio JE; Pezina-Cantú CO; Martínez-Guevara EJ; Ortiz-Treviño JF; Delgado-García GR; Martínez-Jiménez JG; Cruz-Valdez J; Sánchez-Martínez C
Ther Apher Dial; 2017 Oct; 21(5):459-464. PubMed ID: 28805348
[TBL] [Abstract][Full Text] [Related]
8. L-carnitine Improved the Cardiac Function via the Effect on Myocardial Fatty Acid Metabolism in a Hemodialysis Patient.
Kaneko M; Fukasawa H; Ishibuchi K; Niwa H; Yasuda H; Furuya R
Intern Med; 2018 Dec; 57(24):3593-3596. PubMed ID: 30146554
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial.
Maruyama T; Maruyama N; Higuchi T; Nagura C; Takashima H; Kitai M; Utsunomiya K; Tei R; Furukawa T; Yamazaki T; Okawa E; Ando H; Kikuchi F; Abe M
Eur J Clin Nutr; 2019 Feb; 73(2):293-301. PubMed ID: 30353121
[TBL] [Abstract][Full Text] [Related]
10. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.
Schreiber BD
Blood Purif; 2006; 24(1):128-39. PubMed ID: 16361853
[TBL] [Abstract][Full Text] [Related]
11. Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patients.
Csiky B; Bene J; Wittmann I; Sulyok E; Melegh B
Int Urol Nephrol; 2013 Jun; 45(3):847-55. PubMed ID: 22684763
[TBL] [Abstract][Full Text] [Related]
12. Carnitine Profile by Tandem Mass Spectrometry and Dialysis Patients.
Kamei D; Kamei Y; Tanaka N; Tsukada M; Miwa N; Hanafusa N; Mineshima M; Nitta K; Tsuchiya K
Contrib Nephrol; 2019; 198():73-77. PubMed ID: 30991404
[TBL] [Abstract][Full Text] [Related]
13. Significance of Levocarnitine Treatment in Dialysis Patients.
Takashima H; Maruyama T; Abe M
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917145
[TBL] [Abstract][Full Text] [Related]
14. Levocarnitine and dialysis: a review.
Schreiber B
Nutr Clin Pract; 2005 Apr; 20(2):218-43. PubMed ID: 16207659
[TBL] [Abstract][Full Text] [Related]
15. L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.
Vasiljevski ER; Burns J; Bray P; Donlevy G; Mudge AJ; Jones KJ; Summers MA; Biggin A; Munns CF; McKay MJ; Baldwin JN; Little DG; Schindeler A
Am J Med Genet A; 2021 Oct; 185(10):2976-2985. PubMed ID: 34155781
[TBL] [Abstract][Full Text] [Related]
16. The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis.
Chewcharat A; Chewcharat P; Liu W; Cellini J; Phipps EA; Melendez Young JA; Nigwekar SU
PLoS One; 2022; 17(7):e0271307. PubMed ID: 35834513
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the relationship between serum carnitine levels and intradialytic complications in children with kidney failure.
Bazargani B; Mojtahedi SY; Fahimi D; Askarian F; Moghtaderi M; Abbasi A; Samimi M; Bakhtiari Koohsorkhi M
Pediatr Nephrol; 2022 Sep; 37(9):2179-2183. PubMed ID: 35118545
[TBL] [Abstract][Full Text] [Related]
18. Carnitine nutriture of dialysis patients.
Borum PR; Taggart EM
J Am Diet Assoc; 1986 May; 86(5):644-7. PubMed ID: 3700927
[TBL] [Abstract][Full Text] [Related]
19. Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis.
Okubo H; Ando H; Nakadera E; Ikejima K; Shiina S; Nagahara A
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959980
[TBL] [Abstract][Full Text] [Related]
20. [Primary carnitine deficiency in an infant].
Cheng C; Zhang XY; Li JJ
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Sep; 16(9):952-4. PubMed ID: 25229968
[No Abstract] [Full Text] [Related]
[Next] [New Search]
